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Abstract
Background: Considering that grafted gingival tissue might have to be adapted to the receptor area and that
fibroblasts have the ability to respond to bacterial stimuli through the release of various cytokines, this study
investigated whether fibroblasts from the palatal mucosa behave differently when grafted onto the gingival margin
regarding cytokine secretion.
Methods: Biopsies from the palatal mucosa were collected at the time of free gingival graft surgery, and after four
months re-collection was performed upon surgery for root coverage. Fibroblasts were isolated by the explant technique,
cultured and stimulated with Porphyromonas gingivalis (Pg) and Escherichia coli (Ec) LPS for 24 or 48 h for comparative
evaluation of the secretion of cytokines and chemokines, such as IL-6, IL-8/CXCL8, MIP-1α/CCL3, TGF-β, VEGF and CXCL16.
Unstimulated cells were used as the control group. Cells were tested for viability through MTT assay, and secretion of
cytokines and chemokines was evaluated in the cell supernatants by Enzyme-Linked Immunosorbent Assay (ELISA).
Results: Fibroblasts from the palatal mucosa maintained the same secretion pattern of IL-6 when grafted onto the
gingival margin. On the contrary, fibroblasts from the marginal gingival graft showed increased secretion of IL-8/CXCL8
even in the absence of stimulation. Interestingly, MIP-1α/CCL3 secretion by fibroblasts from the marginal gingival graft
was significantly increased after 48 hours of stimulation with Pg LPS and after 24 h with Ec LPS. Only fibroblasts from the
marginal gingival graft showed secretion of TGF-β. VEGF and CXCL16 secretion were not detected by both subsets of
fibroblasts.
Conclusion: Fibroblasts from the palatal mucosa seem to be adapted to local conditions of the site microenvironment
when grafted onto the gingival marginal area. This evidence supports the effective participation of fibroblasts in the
homeostasis of the marginal periodontium through secretion modulation of important inflammatory mediators.
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Background
Gingival tissue exposure to bacterial plaque can result in
tissue inflammation with clinical signs of color change,
size, shape, consistency and bleeding with the possibility
of alveolar bone loss due to periodontal disease progres-
sion [1]. The cumulative effect and repetitive pathological
events to gingival tissue can lead to the occurrence and
progression of gingival recession, especially in cases with
narrow band or absence of attached gingiva [2-4].
According to the American Academy of Periodontology,
periodontal plastic surgery may be indicated to increase
the gingival width, creating a deeper vestibule in sites with
abnormal frenum attachment and inadequate attached
gingiva [5]. Even though the keratinized mucosa width
and gingiva are genetically determined, they can be af-
fected by the presence of bacterial plaque associated with
inflammation or by mechanical interventions [6].
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It has been shown that fibroblasts, besides being the
most important cells in the maintenance and remodeling
of connective tissue extracellular matrix, are involved in
immune and inflammatory host response in periodontal
disease, as they are the predominant structural cells found
in periodontal infections by anaerobic bacteria such as
Porphyromonas gingivalis (Pg) and can be stimulated to
release inflammatory cytokines upon Pg and its subprod-
ucts challenge [7-11]. Besides being sensitive to their own
cytokines and growth factors, they can directly interact
with bacteria and their virulence factors, including lipo-
polysaccharide (LPS) in periodontal lesions [12].
Regarding gingival fibroblasts role in response to Pg LPS
through cytokines release, it was previously demonstrated
that these cells show differential behavior from periodon-
tal ligament from the same donors, confirming the indi-
viduality of the anatomical region in determining the cell
response [9]. Specifically, for IL-6 and IL-8/CXCL8, a
well-known chemokine required for neutrophils recruit-
ment, it was reported that these cells are able to secrete
huge amounts when stimulated by Pg LPS [8,13-15]. Add-
itionally, gingival fibroblasts also secrete the chemokine
MIP-1α/CCL3 implying on monocytes chemoattraction in
periodontal disease [16] as well as TGF-β that induces the
expression of pro-collagen type I [17]. VEGF is another
cytokine related to the etiology of periodontal disease due
to the ability to increase vascular permeability that con-
tributes to the dissemination of inflammation, allowing in-
flammatory mediator release by cells in the inflamed
tissue and enabling the formation of new blood vessels
[18]. Also, the chemokine CXCL16 is induced by other cy-
tokines promoting gingival fibroblasts proliferation and
leukocyte migration into inflamed tissues helping the peri-
odontal tissues reshuffle [19,20]. To the best of our know-
ledge, no previous work has addressed the secretion profile
of the aforementioned cytokines comparing the fibroblasts
from palatal mucosa (usually used as an autogenous donor
site for gingival graft procedures) with cells originated from
marginal gingival area.
Grafted gingival tissue might have to be adapted to the
receptor area and there is a large body of evidence that gin-
gival fibroblasts are able to react to several stimuli through
cytokines and chemokines release, which in turn play an
important role in inflammatory response. Therefore, this
study aimed to investigate whether the secretion of cyto-
kines and chemokines including repair mediators by hu-
man gingival fibroblasts would be modulated when grafted
from the palatal mucosa onto the gingival marginal area in
a free gingival graft procedure.
Methods
Sample collection and fibroblasts primary culture
After approval by the Institutional Review Board of the
Bauru School of Dentistry, University of São Paulo, #055/
2011, three systemically and periodontally healthy individ-
uals (28, 38 and 50 years-old, 3 females) were selected in
Periodontics Clinics, all of whom needed root coverage in
areas with scarce keratinized mucosa. They had no signs
of gingival inflammation, no bleeding on probing or critical
probing depth. All individuals were submitted to anam-
nesis, periodontal clinical examination and radiographic
exams. The inclusion criteria were individuals with deficient
keratinized mucosa, both in quantity and quality, without
systemic complications that could contraindicate the surgi-
cal procedures, and that provided written informed consent
to participate in the study.
The palatal mucosa specimens, sized 3x3 mm, were im-
mediately obtained when an epithelium-connective tissue
graft was removed from the palatal donor site on the pre-
molars area during free gingival graft surgery [21]. After
four months, specimens from gingival graft were obtained
from the marginal area, during a second surgical proced-
ure for root coverage. Fibroblasts were isolated by the ex-
plant technique as previously described [8-11]. Briefly, the
specimens were processed immediately in Dulbecco's
modified Eagle's medium (DMEM; Invitrogen Life Tech-
nologies, Carlsbad, CA, USA) supplemented with 20% fetal
bovine serum (FBS; Gibco, Invitrogen Life Technologies,
Carlsbad, CA, USA). The epithelial layer was removed and
the specimens were minced as small as possible. Tissue
fragments of palatal mucosa or gingival graft were plated
separately in Petri dishes and covered with DMEM supple-
mented with 20% FBS and antibiotics (600 μL/mL penicil-
lin, 300 μL/mL gentamicin sulfate and 100 μL/mL
amphotericin B). The explants were placed in 25 cm2
flasks and incubated at 37°C in a humidified atmosphere
of 5% CO2. The medium (DMEM 10% FBS) was chan-
ged every 2–3 days and cultures were maintained until
fibroblasts reached confluence. After confluence, the fi-
broblasts were harvested and used between the fourth
and eighth passages [8-11].
Fibroblasts stimulation
The cells were seeded in 24 well plates at a density of
2×104 cells/well and incubated at 37°C in a humidified at-
mosphere of 5% CO2 during 18 hours in DMEM 1% FBS.
After overnight adhesion, DMEM containing 1 μg/mL of
Pg LPS (Invivogen, San Diego, CA, USA) or Ec LPS (Invivo-
gen) was added to the wells for 24 or 48 h. Non-stimulated
cells were used as controls. Both Pg LPS and Ec LPS were
ultrapure and purchased from Invivogen.
Phenotypic characterization of fibroblasts
Cells cultured from the palatal mucosa and gingival graft
were characterized as fibroblasts by their morphology and
staining with fibroblast surface protein (FSP; ab 11333,
Abcam, Cambridge, UK) by means of immunostaining
[11]. Cells were seeded in an 8-well plate with 1×104 cells
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per well and incubated at 37°C with 5% CO2 during
18 hours to adhere in subconfluence. Subsequently, the
wells were divided into groups (control, Pg LPS, Ec LPS
and negative control, which was performed without the
primary antibody) in duplicate, to cell stimulation. Cells
were fixed with paraformaldehyde 4% (15 min) and were
washed 3 times with 1x PBS and incubated with PBS BSA
3% (30 min at room temperature) followed by primary
monoclonal antibody incubation to fibroblast surface
marker diluted at 1:100 (2 μg/mL final concentration), and
finally with fluorescein-conjugated secondary antibody
(1:400) (Abcam) at 37°C in the dark for 1 hour. Coverslips
were mounted with mounting medium VECTASHIELD
Hard-Set Mounting Medium containing 49,6-diami-
dino-2-Phenylindole (DAPI; H-1500, Vector Laborator-
ies, Burlingame, CA, USA) and analyzed by confocal
microscope laser scanning (TCS model, SPE, Leica
Mannheim, Germany).
Cell viability
Cell viability was analyzed from enzymatic activity with a
colorimetric assay MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide]. Briefly, cells were washed
with 1× PBS to remove culture medium and MTT (5 mg/
mL) was added to the groups (control, Pg LPS and Ec
LPS) or cell-free wells (blank). The plate was incubated
during 4 hours at 37°C with 5% CO2. After incubation, the
plate was centrifuged (200 g during 7 minutes at 21°C) and
MTT solution was removed to add dimethylsulfoxide
(DMSO; Sigma-Aldrich, St. Louis, MO). The optical dens-
ity of the wells was determined using a plate reader (Fluos-
tar Optima, BMG Labtech, Ortenberg, Germany) in the
wavelength of 570 nm.
Enzyme-linked immunosorbent assay (ELISA)
ELISA was performed following the manufacturer’s in-
structions to determine the protein levels of IL-6 (R&D
System, Minneapolis, MN, EUA), IL-8/CXCL8 (R&D Sys-
tem, Minneapolis, MN, EUA), MIP-1α/CCL3 (R&D Sys-
tem, Minneapolis, MN, EUA), TGF-β (eBioscience, San
Diego, CA, USA), VEGF (PeproTech, London, UK) and
CXCL16 (PeproTech, London, UK). Briefly, plates of 96
wells were incubated with capture antibody anti-IL-6, IL-8/
CXCL8, MIP-1α/CCL3, TGF-β, VEGF or CXCL16 diluted
in 1x PBS buffer. After blocking for 1 hour to avoid non-
specific binding, 100 μl of standard IL-6, IL-8/CXCL8,
MIP-1α/CCL3, TGF-β, VEGF and CXCL16 and culture su-
pernatants were placed. The cytokines were detected by
horseradish peroxidase-labeled monoclonal antibody to
each target after addition of 100 μl anti-human IL-6, IL-8/
CXCL8, MIP-1α/CCL3, TGF-β, VEGF and CXCL16 bio-
tinylated antibodies were placed in each well and incubated
for 2 hours at room temperature. The microplate was
washed to remove unbound enzyme-labeled antibodies.
The amount of horseradish peroxidase bound to each well
was determined by the addition of 100 μl substrate solution.
The reaction was stopped by the addition of 100 μl of 1 M
sulfuric acid, and the plates were read at 450 nm (Synergy™
MXMonochromator Based Multi-Mode Microplate Reader,
BioTek Instruments, Inc, Winooski, VT, USA). The concen-
trations of IL-6, IL-8/CXCL8, MIP-1α/CCL3, TGF-β, VEGF
and CXCL16 were determined by interpolation from a
standard curve and presented as pg/mL for duplicate assays
of duplicate samples of each of the tested conditions.
Statistical analysis
Comparisons for viability through MTT among samples
were performed using One-way ANOVA test followed by
Tukey test. ELISA data normality was verified by the
Kolmogorov-Smirnov method. The statistical differences
were determined by three-way ANOVA followed by Tukey
test. Statistical analyses were performed with STATISTICA
(version 11.0; StatSoft Inc). P values < 0.05 were considered
significant. The results were expressed as mean and one
standard deviation of the mean.
Results
Phenotypic characterization of fibroblasts
Cellular staining with a fibroblast surface marker (FSP)
was performed to confirm the fibroblastic phenotype. Fi-
broblasts were analyzed by immunofluorescence in all
groups (control, Pg LPS, Ec LPS and negative control).
Positive staining was observed for all groups (Figure 1), with
Pg LPS (Figure 1C) and Ec LPS (Figure 1B) groups being
slightly higher. For the negative control group (Figure 1D),
which did not receive primary antibody, no signal was de-
tected. This result confirms the characterization of the cul-
tured cells as fibroblasts.
Cell viability
Cell viability was evaluated after 24 and 48 h, in the con-
trol (non-stimulated) and testing groups (stimulated
with Pg LPS and Ec LPS). There was no difference in
cells viability with the stimuli used after 24 and 48 h
(Figure 2).
Cytokines secretion comparing fibroblasts from the
palatal mucosa with the marginal gingival grafted cells
When the targets of this study were compared between
the two subpopulations of fibroblasts, IL-6 secretion was
statistically significant after 24 and 48 h of Pg LPS stimula-
tion (Figure 3A and B) by both subtypes of fibroblasts
(from the palatal mucosa and gingival graft in marginal
area), and the difference was greater with 48 h (Figure 3B).
On the other hand, the secretion after Ec LPS stimulation
was only statistically significant after 48 h, by both subtypes
of fibroblasts (Figure 3D). Additionally, IL-6 secretion was
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Figure 1 Cells characterization by fibroblast protein surface staining. Cultured cells were immunostained for fibroblast surface protein (FSP)
and analyzed by a confocal microscope at an increase of 63x. (A) control; (B) stimulated by Ec LPS; (C) stimulated by Pg LPS and (D) negative
control, labeled nuclei in blue (DAPI).
Figure 2 Cells viability. Fibroblasts viability challenged with Pg LPS and Ec LPS evaluated at 24 and 48 hours in the control (non-stimulated) and
test groups (stimulated with Pg LPS and Ec LPS) through MTT assay.
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greater by non-stimulated fibroblasts from the marginal
gingival graft (Figure 3).
Fibroblasts from the palatal mucosa secreted more IL-8/
CXCL8 than fibroblasts from the marginal gingival graft
when stimulated by Pg LPS with a statistically significant
difference at 48 h (Figure 4A and B). Also, regarding this
chemokine, fibroblasts from the palatal mucosa showed
an increase at both 24 h and 48 h when stimulated by Ec
LPS (Figure 4C and D), which was not observed by cells
from the marginal gingival graft.
In this study, MIP-1α/CCL3 was observed to be consti-
tutively secreted by both fibroblasts subtypes (Figure 5).
Moreover, there was no statistically significant difference
in MIP-1α/CCL3 secretion between unstimulated fibro-
blasts (control group) and fibroblasts stimulated with Pg
or Ec LPS from the palatal mucosa (Figure 5). However,
statistically significant difference was observed in MIP-1α/
CCL3 secretion after 48 h when fibroblasts from the mar-
ginal gingival graft were stimulated with Pg LPS (Figure 5B)
and after 24 h when challenged by Ec LPS (Figure 5C).
When TGF-β secretion was evaluated, fibroblasts from
the palatal mucosa showed no detectable levels even in
the presence of Pg LPS (Figure 6A and B) or Ec LPS
(Figure 6C and D). On the contrary, fibroblasts from the
marginal gingival graft showed a constitutive TGF-β se-
cretion and there was no statistically significant differ-
ence between stimulated and unstimulated cells, both at
24 h and 48 h (Figure 6). VEGF and CXCL16 secretion
was not detected either on fibroblasts supernatant cul-
tured from the palatal mucosa neither from the marginal
gingival tissue, regardless stimulation by Pg or Ec LPS.
Discussion
Fibroblasts are not a unique cell group across the different
anatomical regions [9,22-24]. They are the predominant
cells in periodontal connective tissue [12], and are involved
in the host immune response by releasing inflammatory cy-
tokines [7] and repair mediators [25,26]. To the best of the
author’s knowledge, this is the first study to investigate and
compare the profile of mediators secretion by human fibro-
blasts cultured from non-marginal palatal mucosa with the
marginal gingival grafted tissue, indicating the differences
or similarities between these cells in contributing for cyto-
kines secretion upon bacterial LPS stimulation.
Figure 3 IL-6 secretion by human fibroblasts cultured from palatal mucosa and marginal gingival graft. A-D: primary cell cultures were
obtained from periodontal tissues from three healthy subjects and, after the fourth passage, were stimulated with LPS from P. gingivalis and from
E. coli in a concentration of 1 μg/mL. Culture medium without stimuli was used as the control. ELISA was performed for the quantification of the
cytokines on the cell culture supernatants. Representative figure of the average of three independent experiments, n = 3. *P < 0.05 was
considered significantly different. PMF = palatine mucosa fibroblasts. GMF =marginal gingival fibroblasts.
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In the present study, it was observed that both fibro-
blasts derived from palatal mucosa and marginal gingival
graft secreted IL-6 cytokine similarly when stimulated by
Pg or Ec LPS. We recognize that it would have been valu-
able to investigate mRNA expression in order to better
understand whether transcript levels would be different
between them. This could give us some information about
possible post transcriptional modifications that can alter
production of cytokines. Previous studies [8,14,15,27,28]
have shown that fibroblasts exposed to bacterial stimuli
such as LPS showed significant IL-6 expression, indicating
the importance of this cytokine in the host immune and
inflammatory response in periodontitis, but the present in-
vestigation also revealed increased IL-6 secretion at 48 h
for both subtypes of fibroblasts. Here, there was IL-6 con-
stitutive secretion by unstimulated cells from the palatal
mucosa and also from the marginal gingival graft, being
statistically significant for the latter. Scheres et al. [14]
showed that non-stimulated gingival fibroblasts expressed
and secreted more IL-6 than periodontal ligament fibro-
blasts. This suggested that gingival fibroblasts have a
higher state of activity because they are more susceptible
to have contact with periodontal pathogens and here we
highlight this important role for both subtypes of gingival
cells.
It is shown here that fibroblasts from the palatal mucosa
only secreted IL-8/CXCL8 chemokine when stimulated
with bacterial LPS. When these cells were grafted onto the
gingival marginal area, after 4 months IL-8/CXCL8 che-
mokine secretion was observed even in the absence of
LPS stimuli. This change in the expression profile may be
related to the closer contact of the cells with bacterial
virulence factors, such as Pg LPS, on the marginal peri-
odontium. Previous studies [9,13-15,29] have shown that
fibroblasts stimulated by Pg LPS are able to produce IL-8,
and fibroblasts from different anatomical regions show
heterogeneity on chemokine profile secretion [14]. There-
fore, it further emphasizes that the heterogeneous secre-
tion of IL-8/CXCL8 in the current study may have
occurred by the environmental influence on the secretion
of fibroblast mediators grafted onto a new anatomical re-
gion, in which there is adaptation and proliferation of
these cells.
When the chemokine MIP-1α/CCL3 was investigated, it
was observed that when fibroblasts from the palatal mu-
cosa were grafted onto the marginal gingival area, they
Figure 4 IL-8/CXCL8 secretion by human fibroblasts cultured from palatal mucosa and marginal gingival graft. A-D: primary cell cultures
were obtained from periodontal tissues from three healthy subjects and, after the fourth passage, were stimulated with LPS from P. gingivalis and
from E. coli in a concentration of 1 μg/mL. Culture medium without stimuli was used as the control. ELISA was performed for the quantification
of the cytokines on the cell culture supernatants. Representative figure of the average of three independent experiments, n = 3. *P < 0.05 was
considered significantly different. PMF = palatine mucosa fibroblasts. GMF =marginal gingival fibroblasts.
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maintained similar cytokine constitutive secretion in the
absence of bacterial stimulation. However, fibroblasts from
the marginal gingival graft showed a higher secretion com-
pared with fibroblasts from the palatal mucosa only after
48 h when stimulated by Pg LPS, showing a time-
dependent expression. Again, the increased chemokine se-
cretion, in this case MIP-1α/CCL3, by fibroblasts from the
marginal gingival graft might have occurred due to prior
stimulation in the marginal area by dental plaque in the sul-
cus, suggesting that these cells present an adaptive behavior
when grafted onto the gingival margin. A previous work by
our group [9] showed that gingival and periodontal liga-
ment fibroblasts behaved differently on MIP-1α/CCL3 se-
cretion when stimulated by Pg LPS, and also showed an
increased MIP-1α/CCL3 secretion when cells were chal-
lenged by Pg LPS in low concentrations such as 0.1 μg/mL,
which increased over time.
Concerning TGF-β secretion, fibroblasts cultured
from the palatal mucosa and from the marginal gingival
graft showed a heterogeneous behavior. Fibroblasts
from the palatal mucosa did not show TGF-β secretion
even against the bacterial stimuli applied. On the contrary,
fibroblasts from the marginal gingival graft secreted TGF-
β, without any difference between stimulated and non-
stimulated cells. One study [30] showed that fibroblasts
from periodontal ligament expressed TGF-β but its pro-
duction was not affected by bacterial LPS, suggesting
that TGF-β accumulate in inflammatory conditions sup-
pressing the cellular immune function, yet without lead-
ing to tissue destruction through stimulation with
bacterial LPS. Another study comparing periodontal
ligament and gingival cells [8] found that TGF-β secre-
tion depended on the stimulus concentration, mainly
for gingival fibroblasts, being higher when challenged
with 10 μg/mL of LPS, whereas the concentration of
1 μg/mL as used in the current study, showed no sig-
nificant differences compared with the non-stimulated
fibroblasts. The increased TGF-β secretion found here
by marginal grafted cells could be related to tissue re-
pair and might have occurred by the continuous repair
need, since the constant presence of dental sulcus
microbiota induces marginal changes.
Figure 5 MIP-1α/CCL3 secretion by human fibroblasts cultured from palatal mucosa and marginal gingival graft. A-D: primary cell
cultures were obtained from periodontal tissues from three healthy subjects and, after the fourth passage, were stimulated with LPS from P.
gingivalis and from E. coli in a concentration of 1 μg/mL. Culture medium without stimuli was used as the control. ELISA was performed for the
quantification of the cytokines on the cell culture supernatants. Representative figure of the average of three independent experiments, n = 3.
*P < 0.05 was considered significantly different. PMF = palatine mucosa fibroblasts. GMF =marginal gingival fibroblasts.
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Lastly, the results indicated that neither fibroblasts
from the palatal mucosa nor from the marginal gingival
graft secreted VEGF nor CXCL16, according to the
stimuli used. Previous studies [31,32] have shown that
human gingival fibroblasts stimulated by LPS, vesicle
and proteins from Pg and Aa extracellular membrane
were able to produce VEGF when stimulated by such
agents. Maybe in this study the time and concentration
of LPS used were not sufficient for the induction of
VEGF. Regarding CXCL16, it was reported that this
expression was induced by other cytokines such as IFN-
γ and TNF-α, and their secretion was mediated by ADAM
10 membrane receptor, which regulates CXCL16 func-
tion on inflamed tissues [33]. Another work [19]
showed that CXCL16 expression by gingival fibroblasts
was controlled by several cytokines such as IL-1β, TNF-
α and IFN- γ. In fact, one could speculate that CXCL16
secretion was not detected in the current study because
fibroblasts were stimulated only by bacterial LPS, and
the action of other cytokines or other stimuli might be
necessary for secretion of CXCL16 by gingival fibro-
blasts [19,33].
The heterogeneous secretion of inflammatory and repair
mediators may indicate that fibroblasts grafted onto a new
anatomical region (gingival margin) may be influenced by
the microenvironment at the moment these cells are in
contact with bacterial products, participating more effect-
ively in the context of the inflammatory response.
Conclusions
Fibroblasts from the palatal mucosa present an adaptive
behavior regarding cytokines secretion when grafted onto
the gingival margin, showing difference in the secretion of
important inflammatory mediators to the marginal peri-
odontium homeostasis.
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